Liver Cyst Treatment
- Home
- /
- Treatments
- /
- Liver
- /
- Neoplasms (Cysts, Tumors)
A diagnosis of liver neoplasm, whether benign cysts or malignant tumors, can feel overwhelming. The liver, critical for detoxification, metabolism, and numerous vital functions, demands immediate and expert care when compromised. In India, liver neoplasms are often undiagnosed or insufficiently treated due to limited diagnostic facilities, high treatment costs, and delayed intervention.
AMS Asia, as a proud member of the Global Age Management Alliance (GAMA), connects patients from India with advanced diagnostic and therapeutic solutions available in Southeast Asia, bringing renewed hope through cutting-edge treatments and comprehensive care.
Liver neoplasms encompass a wide range of conditions:
Cysts: Typically benign, these fluid-filled sacs usually remain asymptomatic and are discovered incidentally. Large cysts, however, can cause pain, abdominal discomfort, or pressure on adjacent organs, necessitating intervention. Common types include simple cysts, complex cysts, and polycystic liver disease.
Tumors: These growths can be benign (hemangiomas, adenomas) or malignant (primary liver cancers such as hepatocellular carcinoma, or metastatic lesions from other cancers). Malignant tumors require rapid intervention to prevent progression and improve patient outcomes.
Accurate diagnosis generally involves advanced imaging methods—ultrasound, CT scans, MRI—and often biopsy procedures for precise characterization and treatment planning. Early detection remains challenging but significantly improves prognosis.
Southeast Asian medical centers offer significant advantages, including highly skilled multidisciplinary teams, state-of-the-art technology, cost-effective solutions, and dedicated patient support. Some leading approaches include:
Minimally Invasive Surgery (MIS): Laparoscopic or robotic-assisted surgery provides effective removal of benign cysts and certain malignant tumors, minimizing scarring, pain, and recovery time.
Radiofrequency (RFA) and Microwave Ablation (MWA): Precise thermal destruction of tumor cells, ideal for tumors unsuitable for surgical removal.
Transarterial Chemoembolization (TACE) and Radioembolization (TARE): Direct delivery of chemotherapy or radioactive materials via the hepatic artery, efficiently destroying tumors by cutting off their blood supply.
Stereotactic Body Radiation Therapy (SBRT): High-dose, precise radiation therapy, significantly sparing healthy liver tissue.
Surgical Resection: Removing affected liver tissue remains the gold standard for many liver tumors, with Southeast Asian surgeons demonstrating exceptional skill in complex resections.
Liver Transplantation: A potentially curative solution for advanced liver cancers or extensive liver damage, with shorter wait times and excellent success rates compared to Western counterparts.
Systemic Therapies: Chemotherapy, targeted therapies, and immunotherapy for cases of advanced or metastatic liver cancers.
At AMS Asia, we go beyond conventional care, leveraging advanced biological treatments:
NK cells naturally target and destroy cancerous cells without harming healthy tissues. AMS Asia utilizes NK cells in liver cancer patients, specifically for hepatocellular carcinoma (HCC) and metastatic liver disease, to enhance immune-mediated tumor suppression.
Oncolytic viruses selectively infect and eliminate cancer cells, simultaneously activating the patient’s immune response against tumors. This approach is especially beneficial for otherwise untreatable liver cancers, significantly improving patient outcomes.
Stem cells facilitate liver regeneration, reduce inflammation, and mitigate fibrosis caused by neoplasms or aggressive treatments. MSC therapy supports faster recovery post-surgery or ablation and can significantly enhance liver function in cirrhosis-complicated cancer cases.
Exosomes derived from MSCs carry potent regenerative factors, promoting liver cell repair, reducing inflammation, and enhancing overall organ recovery. Exosome therapy complements other interventions, accelerating healing and reducing complications.
AMS Asia believes the best outcomes arise from an individualized, comprehensive approach involving:
Detailed diagnostic evaluations to tailor precise interventions.
Integration of advanced biotechnological therapies (NK cells, oncolytic viruses, stem cells, exosomes) alongside conventional treatments.
Collaborative care involving hepatologists, oncologists, surgeons, and regenerative medicine specialists.
AMS Asia, as part of Global Age Management Alliance (GAMA), provides a seamless, end-to-end experience:
Expert Consultation: Thorough review and customized treatment recommendations.
Top-Tier Medical Centers: Access to world-class hospitals and renowned specialists.
Complete Logistic Support: Medical visas, accommodations, transportation, and language assistance.
Transparent, Competitive Pricing: Clear cost structures with affordable solutions.
We warmly welcome collaboration with Indian healthcare providers and medical tourism agencies. Partnering with AMS Asia allows you to:
Offer patients access to exclusive treatments unavailable domestically.
Enhance your clinical reputation through association with world-renowned experts and therapies.
Participate in joint training, educational initiatives, and research collaborations.
Expand service offerings, significantly increasing patient satisfaction and revenue potential.
Do not let liver neoplasms limit your life. AMS Asia stands ready to guide you toward optimal care through our advanced network in Southeast Asia.
Whether you are a patient seeking advanced treatment or a healthcare provider interested in collaboration, AMS Asia is your trusted partner for superior healthcare solutions.
Contact AMS Asia today to explore your options, access life-changing treatments, and establish meaningful partnerships.